Long-term neurologic outcomes of COVID-19
Top Cited Papers
Open Access
- 22 September 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 28 (11), 2406-2415
- https://doi.org/10.1038/s41591-022-02001-z
Abstract
The neurologic manifestations of acute COVID-19 are well characterized, but a comprehensive evaluation of postacute neurologic sequelae at 1 year has not been undertaken. Here we use the national healthcare databases of the US Department of Veterans Affairs to build a cohort of 154,068 individuals with COVID-19, 5,638,795 contemporary controls and 5,859,621 historical controls; we use inverse probability weighting to balance the cohorts, and estimate risks and burdens of incident neurologic disorders at 12 months following acute SARS-CoV-2 infection. Our results show that in the postacute phase of COVID-19, there was increased risk of an array of incident neurologic sequelae including ischemic and hemorrhagic stroke, cognition and memory disorders, peripheral nervous system disorders, episodic disorders (for example, migraine and seizures), extrapyramidal and movement disorders, mental health disorders, musculoskeletal disorders, sensory disorders, Guillain–Barré syndrome, and encephalitis or encephalopathy. We estimated that the hazard ratio of any neurologic sequela was 1.42 (95% confidence intervals 1.38, 1.47) and burden 70.69 (95% confidence intervals 63.54, 78.01) per 1,000 persons at 12 months. The risks and burdens were elevated even in people who did not require hospitalization during acute COVID-19. Limitations include a cohort comprising mostly White males. Taken together, our results provide evidence of increased risk of long-term neurologic disorders in people who had COVID-19.Keywords
Funding Information
- U.S. Department of Veterans Affairs
- American Society of Nephrology
This publication has 50 references indexed in Scilit:
- COVID-19, microangiopathy, hemostatic activation, and complementJCI Insight, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- StatPearls2020
- Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood AtlasThe New England Journal of Medicine, 2018
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- A tutorial on propensity score estimation for multiple treatments using generalized boosted modelsStatistics in Medicine, 2013
- Negative ControlsEpidemiology, 2010
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- 6. A Diagnostic Routine for the Detection of Consequential Heterogeneity of Causal EffectsSociological Methodology, 2008